C12Y 301/21001
Deoxyribonuclease i
Official title: Deoxyribonuclease I (3.1.21.1)
C12Y301/21001 (Deoxyribonuclease i) appears on 136 US grants and 278 published applications in this corpus.
Search patents in C12Y- Granted patents
- 136
- Published applications
- 278
- Assignees
- 118
- Inventors
- 346
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 2 |
| 2008 | 1 | 1 |
| 2009 | 1 | 4 |
| 2010 | 0 | 6 |
| 2011 | 0 | 1 |
| 2012 | 2 | 3 |
| 2013 | 4 | 4 |
| 2014 | 6 | 11 |
| 2015 | 5 | 16 |
| 2016 | 9 | 16 |
| 2017 | 9 | 19 |
| 2018 | 5 | 9 |
| 2019 | 5 | 23 |
| 2020 | 9 | 20 |
| 2021 | 10 | 21 |
| 2022 | 16 | 24 |
| 2023 | 15 | 21 |
| 2024 | 8 | 26 |
| 2025 | 13 | 26 |
| 2026 | 8 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions comprising a CAS12I polypeptide and uses thereof29 Sep 2026US 12,747,457 B2Arbor Biotechnologies, Inc.
- Polypeptide variants29 Sep 2026US RE51,046 E1Novozymes A/S
- Engineered cells secreting therapeutic enzymes18 Aug 2026US 12,709,739 B2Cartesian Therapeutics, Inc.
- Methods for co-activating in vitro non-standard amino acid (nsAA) incorporation and glycosylation in crude cell lysates12 May 2026US 12,624,375 B2Northwestern University
- Mutant DNase1L3 with improved serum half-life17 Mar 2026US 12,577,571 B2Texas Tech University System
- Mutated v-type crispr enzyme and use thereof27 Aug 2026US 2026/0250744 A1Beijing Synsorbio Technology Co., Ltd.
- Tetz-proteins and prion-like proteins and associated methods6 Aug 2026US 2026/0227416 A1
- Methods, compositions, and kits for detecting spatial chromosomal interactions23 Jul 2026US 2026/0209833 A110x Genomics, Inc.
- Methods of making rna by splinted ligation and compositions thereof16 Jul 2026US 2026/0201394 A1Orbital Therapeutics, Inc.
- Salt active nuclease compositions and methods9 Jul 2026US 2026/0193628 A1New England Biolabs, Inc.
Most cited
By later US patents
- Method for treating oncological diseases36US 7,612,032 B22009
- Method of and compounds for treatment for cystic fibrosis31US 5,384,128 AUniversity of Alabama Research Foundation · 1995
- Method for treating delayed-type hypersensitivity22US 8,535,663 B2CLS Therapeutics Limited · 2013
- Method for treating systemic DNA mutation disease21US 8,388,951 B2CLS Therapeutics Limited · 2013
- Method for treating a reduction of fertility20US 8,916,151 B2CLS Therapeutics Limited · 2014